LONZA N | 573.60 / +4.71% |
Date/Time | 05/27 / 16:44 |
Chg. / Chg.(%) | 25.80 / +4.71% |
Bid | 573.20 / 124 |
Ask | 573.60 / 121 |
Open | 557.80 |
Previous Close | 547.80 |
High | 576.40 |
Low | 556.40 |
Volume [CHF] | 52,440,398.50 |
Volume [Units] | 92,732 |
Price fixings | 4313 |
ISIN | CH0013841017 |
Security | LONN |
Exchange | SIX Swiss Exchange |
Type | Stock |
Exchange | Last | Volume | |
---|---|---|---|
SIX Swiss Ex.. | 573.60 | ![]() |
92,732 |
London Domes.. | 573.20 | ![]() |
56,230 |
Cboe Europe .. | 573.00 | ![]() |
45,783 |
Cboe Europe .. | 573.00 | ![]() |
20,152 |
Turquoise | 573.60 | ![]() |
10,626 |
Nasdaq Other.. | 601.8800 | ![]() |
77 |
Lang & Schwa.. | 556.800 | ![]() |
|
Mexico | 11,590.38 | ![]() |
295 |
TradeGate | 294.000 | 298 | |
Frankfurt | 293.9000 | 63 | |
Düsseldorf | 291.20 | 0 | |
München | 291.30 | 0 | |
Berlin | 296.90 | 0 | |
Hamburg | 291.30 | 0 | |
gettex | 296.100 | ||
Singapore | 79.97 | 500 | |
EUREX | Options |
News
- Finch Therapeutics Announces Additions to Senior Leadership Team
02/10/2022 / 13:00 - GlobeNewswire - Kamran Tahamtanzadeh Joins Inanovate, Inc. as New Chief Executive Officer
01/04/2022 / 17:45 - GlobeNewswire - Codiak BioSciences Reports Third Quarter 2021 Financial Results and Recent Operational Progress
11/04/2021 / 21:01 - GlobeNewswire - Lonza to Acquire Codiak BioSciences Exosomes Manufacturing Facility and Establish a Long-Term Strategic Collaboration
11/02/2021 / 13:00 - GlobeNewswire - Moderna, VIA and Benchling Receive “Tell Awards” for FDI in Switzerland
10/12/2021 / 22:53 - GlobeNewswire